IPP Bureau
Tata 1mg optimises e-commerce operations with Unicommerce
By IPP Bureau - May 21, 2025
IICP and Indegene partner to enable more inclusive society
By IPP Bureau - May 20, 2025
IICP is a registered charitable society working in the disability sector since 1974
Zydus Wellness records a growth of 30% in net profit in FY25
By IPP Bureau - May 20, 2025
EBITDA for the period rose by 23.2% to Rs. 3,797 million
Global Health posts Q4 FY25 consolidated PAT at Rs. 101.4 Cr
By IPP Bureau - May 20, 2025
Global Health has posted net profit of Rs. 481.43 crores for the Financial Year ended March 31, 2025
Crosslay Remedies acquires land adjacent to Max Super Speciality Hospital, Vaishali
By IPP Bureau - May 20, 2025
CRL shall invest another Rs. 200 crore for creation of additional beds
Indraprastha Medical Corporation posts Q4 FY25 PAT at Rs. 41.01 Cr
By IPP Bureau - May 18, 2025
Indraprastha Medical Corporation has reported total income of Rs. 340.10 crores during the period ended March 31, 2025
Alivus Life Sciences reports Q4 FY25 PAT at Rs. 141.86 Cr
By IPP Bureau - May 18, 2025
The company has posted net profit of Rs. 485.62 crores for the Financial Year ended March 31, 2025
Hikal posts Q4 FY25 consolidated PAT at Rs. 50 Cr
By IPP Bureau - May 18, 2025
In Q4 FY25, our pharmaceutical business reported revenue growth of 20% to Rs 351 crore and EBIT growth of 65% to Rs 55 croe, on QoQ basis
Briefs: Dr. Reddy's Laboratories, Relonchem, Shilpa Pharma Lifesciences and Shanmuga Hospital
By IPP Bureau - May 18, 2025
Shilpa Pharma Lifesciences, Unit-1, received EIR from USFDA
Sun Pharma gets FDA approval for new device to treat skin disease
By IPP Bureau - May 18, 2025
Punita Lal Joins Lupin Board as Additional Director
By IPP Bureau - May 18, 2025
She has held senior positions at Coca-Cola in China and PepsiCo in India
Lupin receives USFDA approval for Rivaroxaban Tablets
By IPP Bureau - May 18, 2025
Abbott India posts Q4 FY25 net profit at Rs. 367.04 Cr
By IPP Bureau - May 18, 2025
The company has posted net profit of Rs. 1,414.44 crores for the Financial Year ended March 31, 2025
Wanbury posts Q4 FY25 consolidated PAT at Rs. 20.25 Cr
By IPP Bureau - May 18, 2025
The company has posted net profit of Rs. 30.53 crores for the Financial Year ended March 31, 2025
